Glucose Metabolism Disorders  >>  niacin extended-release formulation  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
niacin extended-release formulation / Generic mfg.
CERTAIN, NCT01239004: Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy

Completed
4
140
US
Placebo, Colesevelam, Welchol
Radiant Research
Dyslipidemia, Hyperlipidemia, Hyperglycemia
08/11
08/11

Download Options